The process of drug development is challenging. Some drugs pass the FDA muster easily, while some face a host of hurdles before getting the official stamp of approval. So far, 40 novel drugs have been approved for this year, compared to just 22 in 2016. Let's take a look at the drugs that crossed the regulatory finish line in November.
from RTT - Biotech http://ift.tt/2j7NDW7
via IFTTT
No comments:
Post a Comment